Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Clinical trial NCT04861480 · UNKNOWN

Trial details

NCT number: NCT04861480
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2021-06-16
Primary completion: 2023-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.